Importantly, the researchers established a correlation between high MALAT-1 expression in ccRCC patients and advanced clinical features, as well as a shorter overall survival time compared to individuals with lower MALAT-1 expression levels. Here, MALAT1 is linked to nonpapillary renal cell carcinoma.